| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 153.941 | 167.810 | 167.722 | 191.905 | 196.520 | 182.135 | 245.269 | 255.131 | 307.010 | 332.631 |
| Total Income - EUR | 153.948 | 167.820 | 168.829 | 195.530 | 198.848 | 192.790 | 245.287 | 260.174 | 307.427 | 339.720 |
| Total Expenses - EUR | 102.047 | 130.275 | 136.615 | 136.934 | 140.727 | 136.391 | 191.512 | 173.008 | 203.468 | 222.923 |
| Gross Profit/Loss - EUR | 51.902 | 37.545 | 32.214 | 58.596 | 58.120 | 56.399 | 53.776 | 87.167 | 103.960 | 116.797 |
| Net Profit/Loss - EUR | 43.598 | 31.520 | 30.123 | 56.641 | 56.132 | 54.571 | 51.323 | 84.615 | 100.890 | 106.818 |
| Employees | 8 | 9 | 10 | 11 | 11 | 8 | 10 | 11 | 8 | 10 |
Check the financial reports for the company - Bioanaliza Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 94.560 | 127.969 | 121.464 | 124.840 | 112.782 | 106.021 | 91.409 | 104.294 | 101.192 | 98.331 |
| Current Assets | 52.081 | 23.250 | 23.680 | 36.330 | 38.756 | 51.723 | 55.376 | 66.919 | 85.395 | 56.647 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 12.658 | 13.273 | 13.610 | 16.382 | 18.344 | 13.381 | 15.320 | 17.221 | 27.288 | 2.789 |
| Cash | 39.423 | 9.977 | 10.070 | 19.948 | 20.412 | 38.342 | 40.056 | 49.698 | 58.107 | 53.858 |
| Shareholders Funds | 78.534 | 40.078 | 69.522 | 64.900 | 64.230 | 62.515 | 59.091 | 92.408 | 108.658 | 38.373 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 68.106 | 111.141 | 75.622 | 96.270 | 87.308 | 95.229 | 87.693 | 78.804 | 77.929 | 116.605 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8691 - 8691" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Bioanaliza Srl